FDA approves flexible endoscopic suturing system — 4 insights

Written by Eric Oliver | November 29, 2017 | Print  |

The FDA awarded Apollo Endosurgery's OverStitch Sx system FDA 510(k) clearance.

Here's what you should know:

1. OverStitch Sx is an endoscopic suturing system that works with several single-channel flexible endoscopes.

2. The existing version of OverStitch was only compatible with a limited number of dual-channel endoscopes. OverStitch Sx eliminates that limitation.

3. Specifically, OverStitch Sx works with most single-channel endoscopes with diameters between 8.8 mm and 9.8 mm.

4. The Sx system will be available in the U.S. and Europe in the first half of 2018.

Apollo Endosurgery's CMO Christopher Gostout said, "Endoscopic suturing is quickly becoming a global standard of care for a variety of endoscopic procedures backed by a growing level of clinical evidence. The launch of OverStitch Sx will allow suturing technology to be available to nearly any physician with access to an endoscope. Broader physician access to endoscopic suturing allows for greater patient access to a variety of minimally invasive endoscopic treatments."

More articles on gastroenterology:
9 GI leaders to know for November
Stock market week-in-review for 5 large GI companies — Nov. 20-24
6 insights into Crohn's on a global level — US has 993k cases

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.